US Broker Ratings

Doximity, Inc. (DOCS) Stock Analysis: Healthcare’s Digital Pioneer with a 49% Upside Potential

Doximity, Inc. (NYSE: DOCS) has carved a unique niche in the healthcare sector with its innovative digital platform tailored for medical professionals. As a company operating in the health information..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotechnology Powerhouse with 19.66% ROE

Krystal Biotech, Inc. (NASDAQ: KRYS), a rising star in the biotechnology sector, has captured investor attention with its impressive financial metrics and innovative genetic medicines. With a robust market capitalization..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

iRhythm Technologies, Inc. (IRTC): Investor Outlook with 23.68% Potential Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) is a standout player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $5.75 billion, iRhythm has carved out..

Regencell Bioscience Holdings (RGC): Unpacking the Dynamics of a $8 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands as a significant player in the healthcare sector, specifically within the niche of Traditional Chinese Medicine (TCM). With a market capitalization of $8.03..

Telix Pharmaceuticals Limited (TLX): Investor Outlook with a Promising 115.84% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) is making waves in the biotechnology sector with its innovative approach to radiopharmaceuticals. As a commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, Telix is..

Guardant Health, Inc. (GH) Investor Outlook: Analyzing a 38.5% Revenue Growth in the Precision Oncology Space

Guardant Health, Inc. (NASDAQ: GH) has emerged as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.25 billion, this..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Analyzing a 20% Potential Upside in the CNS Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a notable player in the biotechnology sector, presents an intriguing opportunity for investors with its focus on developing cutting-edge therapies for central nervous system (CNS)..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Volatility in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) presents a compelling case study of the biotechnology industry’s inherent volatility. With its focus on developing groundbreaking RNA-targeted therapeutics and gene therapies, Sarepta is at..

Universal Health Services, Inc. (UHS): Stock Analysis Reveals Potential Upside and Strong Buy Ratings

Universal Health Services, Inc. (NYSE: UHS) has emerged as a compelling investment opportunity within the healthcare sector, especially for those with an eye on the medical care facilities industry. Headquartered..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with a 26% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a biopharmaceutical company hailing from Denmark, is making waves in the biotechnology sector with its innovative TransCon technology. With a market capitalization of $12.55 billion,..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Powerhouse With 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector with its innovative approach to tackling metabolic diseases. Headquartered in West Conshohocken, Pennsylvania, Madrigal focuses on developing novel..

Qiagen N.V. (QGEN)

⚠️ No article content returned.

..

Masimo Corporation (MASI) Stock Analysis: Healthcare Innovator with a 29.69% Potential Upside

Masimo Corporation (NASDAQ: MASI) stands out in the healthcare sector, particularly within the medical devices industry, for its innovative approach to patient monitoring technologies. Headquartered in Irvine, California, Masimo has..

BridgeBio Pharma, Inc. (BBIO): Growth Potential with a 14.95% Upside Amidst Biotech Innovations

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its innovative approach to addressing genetic diseases and cancers. With a current market cap of $14.19 billion,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unlocking Growth Potential with Innovative Treatments

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is gaining attention for its innovative approach to treating serious metabolic diseases. Headquartered in South San Francisco, California,..

Cooper Companies, Inc. (COO) Stock Analysis: 9.80% Potential Upside in Healthcare Innovator

The Cooper Companies, Inc. (NYSE: COO) stands out in the healthcare sector, particularly within the medical instruments and supplies industry, thanks to its dual focus on contact lenses and women’s..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth with a 1.67% Potential Upside

Bruker Corporation (NASDAQ: BRKR), a formidable player in the healthcare sector, specializes in developing and manufacturing cutting-edge scientific instruments and analytical solutions. With a market cap of $7.3 billion, Bruker..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare’s Dynamic Landscape with Modest Upside

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, specializes in the design and manufacturing of single-use medical devices. Headquartered in Wayne, Pennsylvania, this company serves a diverse range..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Exploring a 21% Upside Potential in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) has captured investor interest, showcasing a significant potential upside of 21.41% according to analysts’ average target price projections. As a commercial-stage biopharmaceutical company, Rhythm Pharmaceuticals..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds